McGevna Moira A, Adler Lily S F, Lu James Y, Ciaramella Michael A, Rahimi Saum A, Beckerman William E
Rutgers Robert Wood Johnson Medical School, Piscataway, NJ.
Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA.
Ann Vasc Surg. 2025 Nov;120:413-421. doi: 10.1016/j.avsg.2025.07.018. Epub 2025 Jul 18.
Previous research has shown that frailty, using the modified frailty index (mFI-11), does not correlate with 30-day outcomes after repair of a ruptured abdominal aortic aneurysm (rAAA). However, there are no studies to date investigating whether mFI-11 is associated with longer-term mortality and morbidity after rAAA repair. The aim of this study was to evaluate whether mFI-11 can be used as a risk assessment tool for predicting 1-year mortality and morbidity in patients undergoing both open and endovascular rAAA repair.
We conducted a retrospective analysis of all patients undergoing rAAA repair at a single tertiary-care center from January 2011 to November 2022. Frailty was assessed for each patient using the mFI-11, a validated frailty metric based on the Canadian Study of Health and Aging, and was defined as an mFI-11 ≥ 0.27. The primary outcome was 1-year mortality. Logistic regression, cox regression, and receiver operating characteristic (ROC) curves were used to assess mFI-11 with 1-year morbidity and mortality. Kaplan-Meier analysis was used to compare rates of survival. Categorical and continuous data were compared using χ and Student's t-tests, respectively. For all tests, a P value of <0.05 was considered statistically significant.
Seventy-eight patients were identified during the study period (35 frail vs. 43 nonfrail) with a median follow-up of 7 months (6 months frail versus 10 months nonfrail) and a 1-year mortality rate of 40% overall (49% frail versus 33% nonfrail, P = 0.10). Multivariable analysis showed no correlation between frailty and reintervention (odds ratio 1.6 [95% confidence interval 0.1-27.6], P = 0.75), dialysis dependence (0.8 [0.1-9.2], P = 0.83), home oxygen use (1.6 [0.2-13.0], P = 0.6), and dependent mobility (0.8 [0.12-4.7], P = 0.79). The area under the ROC curve for mFI-11 was 0.58 for 1-year mortality (P = 0.2). Kaplan-Meier analysis showed no difference in rates of survival between frail and nonfrail patients (P = 0.29).
mFI-11 was not predictive of 1-year outcomes after open or endovascular rAAA repair. Other metrics are needed to more accurately assess long term risk to enable better patient and family counseling after repair of rAAA.
先前的研究表明,使用改良衰弱指数(mFI-11)评估的衰弱与腹主动脉瘤破裂(rAAA)修复术后30天的预后无关。然而,迄今为止尚无研究调查mFI-11是否与rAAA修复术后的长期死亡率和发病率相关。本研究的目的是评估mFI-11是否可作为预测接受开放和血管腔内rAAA修复患者1年死亡率和发病率的风险评估工具。
我们对2011年1月至2022年11月在一家三级医疗中心接受rAAA修复的所有患者进行了回顾性分析。使用mFI-11对每位患者进行衰弱评估,mFI-11是一种基于加拿大健康与老龄化研究验证的衰弱指标,mFI-11≥0.27被定义为衰弱。主要结局是1年死亡率。采用逻辑回归、Cox回归和受试者工作特征(ROC)曲线评估mFI-11与1年发病率和死亡率的关系。采用Kaplan-Meier分析比较生存率。分类数据和连续数据分别使用χ检验和Student t检验进行比较。所有检验中,P值<0.05被认为具有统计学意义。
研究期间共纳入78例患者(35例衰弱患者与43例非衰弱患者),中位随访时间为7个月(衰弱患者6个月,非衰弱患者10个月),总体1年死亡率为40%(衰弱患者49%,非衰弱患者33%,P = 0.10)。多变量分析显示,衰弱与再次干预(比值比1.6 [95%置信区间0.1-27.6],P = 0.75)、透析依赖(0.8 [0.1-9.2],P = 0.83)、家庭吸氧(1.6 [0.2-13.0],P = 0.6)和行动依赖(0.8 [0.12-4.7],P = 0.79)之间无相关性。mFI-11预测1年死亡率的ROC曲线下面积为0.58(P = 0.2)。Kaplan-Meier分析显示,衰弱患者和非衰弱患者的生存率无差异(P = 0.29)。
mFI-11不能预测开放或血管腔内rAAA修复术后1年的结局。需要其他指标来更准确地评估长期风险,以便在rAAA修复后为患者及其家属提供更好的咨询。